Novavax
NVAX
NVAX
388 hedge funds and large institutions have $7.69B invested in Novavax in 2021 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 100 increasing their positions, 140 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3.41% less ownership
Funds ownership: 60.99% → 57.58% (-3.4%)
29% less repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 140
Holders
388
Holding in Top 10
6
Calls
$893M
Puts
$797M
Top Buyers
| 1 | +$551M | |
| 2 | +$192M | |
| 3 | +$122M | |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
+$95.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$86.4M |
Top Sellers
| 1 | -$143M | |
| 2 | -$135M | |
| 3 | -$116M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$103M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$64.6M |